Up to $1,000,000 of Seed Capital to Support Aspiring Cannabis Entrepreneurs
TORONTO, May 16, 2018 /CNW/ - Canopy Rivers Corporation ("Canopy Rivers", or the "Company") is excited to help foster growth in the Canadian cannabis landscape by hosting a pitch day for cannabis entrepreneurs ahead of impending adult use legalization. In accordance with the proposed regulations underneath the Cannabis Act (Bill C-45) and the new "micro" class of licenses, the Company is offering up to $1,000,000 of seed capital to support a diverse range of aspiring cannabis entrepreneurs.
Canopy Rivers has developed an ecosystem of complimentary and best-in-class cannabis operating companies across all the various niches of the cannabis economy. With the proposed regulations outlining licenses for micro-growers, micro-processors, hemp production, lab testing, retailers, and other emerging segments that have been underrepresented in the industry so far, Canopy Rivers is eager to create a more inclusive and diverse cannabis industry.
Entrepreneurs should ideally be in process of, or have the intention to, apply to Health Canada for a micro-license under the proposed Cannabis Act (Bill C-45). Interested parties can apply at the Canopy Rivers website and a select few will be invited to pitch live in front of a panel of industry professionals and representatives of Canopy Rivers in Vancouver at the International Cannabis Business Conference on June 25th, 2018.
"The cannabis sector's investment prospects are no longer exclusively tied to medical cannabis cultivation at scale, and innovative businesses are emerging," said Daniel Pearlstein, Executive Vice President, Head of Business Development, Canopy Rivers Corporation. "We are excited to help foster growth and innovation by supporting startup cannabis entrepreneurs".
The winners, like all members of the Canopy Rivers family, will benefit from Canopy Growth's world-leading expertise across the full cannabis value chain. This unique platform allows entrepreneurs to maintain more control of their operations, develop proprietary brands and strategies, and strengthen their position within Canada's globally leading network of emerging cannabis companies and brands.
The company is calling on forward thinking entrepreneurs to apply and position their Micro Cannabis business for a Macro Impact.
Accelerating The Next Wave Of Growth
About Canopy Rivers:
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth (TSX:WEED) to identify strategic counterparties seeking financial and/or operating support and affiliation with the Canopy Growth group of companies. The result is an ecosystem of complementary and best-in-class cannabis operating companies that is representative of all the various niches in this newly developing cannabis economy. As the portfolio continues to develop, constituents benefit from opportunities to join forces with Canopy Growth and collaborate among themselves, resulting in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and the entire ecosystem of portfolio companies.
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.
Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eight cannabis production sites with over 2.4 million square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The Company has operations in seven countries across four continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. For more information visit www.canopygrowth.com.
SOURCE Canopy Growth Corporation
For further information: Daniel Pearlstein, Executive Vice President, Head of Business Development, Canopy Rivers Corporation, email@example.com, 647-475-1115